 Biofrontera AG NASDAQ: BFRA; Frankfurt Stock Exchange: B8F the Company, an international biopharmaceutical company, an international biopharmaceutical company, announces the results of the Annual General Meeting AGM held today on May 28, 2020. The shareholders present represented 76.31 of the registered share capital. The shareholders approved the resolutions 2 to 6 proposed by the Management Board and Supervisory Board, published in the Federal Gazette on April 21, 2020. 